Primary Peritoneal Serous Adenocarcinoma

general

A rare, serous adenocarcinoma that arises from the lining of the peritoneum. It affects females. The clinical behavior and pathologic characteristics are similar to the serous adenocarcinoma that arises from the ovary.

78

Centers

195

Active Trials

Cancer Funding

Specific Cancer Types(2)

Top Centers for Primary Peritoneal Serous Adenocarcinoma(78)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.0
2
NCI Comprehensive
High-Volume Research Center
72.0
372.0
4
High-Volume Research Center
72.0
5
NCI Comprehensive
Active Research Program
69.4
6
NCI Clinical
Active Research Program
69.4
7
Active Research Program
69.4
8
Active Research Program
69.4
969.4
10
NCI Comprehensive
Active Research Program
58.1
11
NCI Comprehensive
Active Research Program
58.1
12
NCI Comprehensive
Active Research Program
58.1
13
NCI Comprehensive
Active Research Program
58.1
14
NCI Comprehensive
Active Research Program
58.1
15
NCI Comprehensive
Active Research Program
58.1
16
NCI Comprehensive
Active Research Program
58.1
17
NCI Comprehensive
Active Research Program
58.1
18
NCI Comprehensive
Active Research Program
58.1
19
NCI Comprehensive
Active Research Program
58.1
20
NCI Comprehensive
Active Research Program
58.1
21
NCI Comprehensive
Active Research Program
58.1
22
NCI Comprehensive
Active Research Program
58.1
23
NCI Comprehensive
Active Research Program
58.1
24
NCI Comprehensive
Active Research Program
58.1
25
NCI Comprehensive
Active Research Program
58.1
26
Active Research Program
58.1
27
NCI Comprehensive
Active Research Program
58.1
28
Active Research Program
58.1
29
NCI Comprehensive
Active Research Program
58.1
30
NCI Clinical
Active Research Program
58.1
31
NCI Comprehensive
Active Research Program
58.1
32
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
58.1
33
NCI Comprehensive
Active Research Program
58.1
34
Active Research Program
58.1
35
NCI Comprehensive
Active Research Program
58.1
36
Active Research Program
58.1
37
Active Research Program
58.1
38
Active Research Program
58.1
39
Active Research Program
58.1
40
Active Research Program
58.1
41
Active Research Program
58.1
42
Active Research Program
58.1
43
Active Research Program
58.1
44
NCI Comprehensive
Active Research Program
42.6
45
NCI Comprehensive
Active Research Program
42.6
46
NCI Comprehensive
Active Research Program
42.6
47
NCI Comprehensive
Active Research Program
42.6
48
NCI Comprehensive
Active Research Program
42.6
49
NCI Comprehensive
Active Research Program
42.6
50
NCI Comprehensive
Active Research Program
42.6
51
NCI Comprehensive
Active Research Program
42.6
52
NCI Comprehensive
Active Research Program
42.6
53
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
42.6
54
NCI Comprehensive
Active Research Program
42.6
55
NCI Comprehensive
Active Research Program
42.6
56
NCI Clinical
Active Research Program
42.6
57
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
42.6
58
Active Research Program
42.6
59
Active Research Program
42.6
60
Active Research Program
42.6
61
Active Research Program
42.6
62
Active Research Program
42.6
63
Active Research Program
42.6
64
NCI Comprehensive
Contributing Research Center
33.0
65
NCI Comprehensive
Contributing Research Center
33.0
66
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Contributing Research Center
33.0
67
NCI Comprehensive
Contributing Research Center
33.0
68
NCI Comprehensive
Contributing Research Center
33.0
69
NCI Clinical
Contributing Research Center
33.0
70
NCI Comprehensive
Contributing Research Center
33.0
71
NCI Comprehensive
Contributing Research Center
33.0
72
NCI Basic_laboratory
Contributing Research Center
33.0
73
Contributing Research Center
33.0
74
Contributing Research Center
33.0
75
Contributing Research Center
33.0
76
Contributing Research Center
33.0
7728.7
7828.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →